Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO TEST FINALE
NL-OMON58958Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of allopurinol in gout (2 arms), sponsored by Sint Maartenskliniek. Primary endpoints: Adapted gout remission during the last 6 months of 24-month follow-up and Incremental cost-effectiveness. Started Jul 2024; status: completed.
02
Drugs
allopurinol
03
Conditions
gout
Beyond the preview
Go deeper on NL-OMON58958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58958.